Press release
NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS
Total revenue of $211.8 million for Q1 2025 versus $67.5 million for Q1 2024, an increase of 214.0% Net income attributable to Nutex Health Inc. of $21.2
About this update from Nutex Health Inc.
[{"type":"text","content":"\n \n \n Total revenue of $211.8 million for Q1 2025\n \n \n versus $67.5 million for Q1 2024, an increase of 214.0%\n \n \n \n \n Net income attributable to Nutex Health Inc. of $21.2 million for Q1 2025 versus net loss of $0.4 million for Q1 2024, an increase of $21.6 million.\n \n \n \n \n Diluted income per share of $3.33 for Q1 2025 versus a loss per share of $0.08 for Q1 2024\n \n \n \n \n EBITDA of $51.5 million for Q1 2025 versus $7.1 million for Q1 2024, an increase of 624.7%\n \n \n \n \n Adjusted EBITDA of $72.8 million for Q1 2025 versus $(0.4) million for Q1 2024, an increase\n \n \n of $73.2 million\n \n \n \n \n Net cash from operating activities of $51.0 million for Q1 2025\n \n \n \n \n The Company believes its arbitration efforts through the Independent Dispute Resolution (IDR) process have resulted in an increase in fair and reasonable payments from insurance companies\n \n \n \n \n HOUSTON, Nov. 18, 2025 /PRNewswire/ -- Nutex Health Inc. (\"Nutex Health\" or the \"Company\") (NASDAQ: NUTX), today announced restated first quarter financial results for the three months ended March 31, 2025. Nutex Health is a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks.\n \n First Quarter 2025 Restatement Background\n \n As previously disclosed in Form 8-K filed on August 21, 2025, the Audit Committee of the Board of Directors of Nutex Health, after consultation with the Chief Financial Officer, concluded that the Company's previously issued condensed consolidated unaudited financial statements as of and for the three months ended March 31, 2025 contained in the originally filed Form 10-Q should be restated for the items described below. The major balance sheet accounts affected by these non-cash adjustments are as follows:\n \n Corrected the classification of non-cash, stock-based compensation obligations totaling $20.7 million related to under construction and ramping hospitals from equity to liabilities.\n Reclassified related-party accounts payable balances of $3.5 million from liabilities to equity.\n Reclassified $2.9 million of restricted balances out of cash and cash equivalents and into short-term investments.\n Increased accrued income tax expense b...